OLAPLEX INVESTOR ALERT: Kaplan Fox & Kilshiemer LLP Notifies Olaplex Investors of a Class Action Lawsuit and Upcoming Deadline
November 29, 2022 14:08 ET | Kaplan Fox & Kilsheimer LLP
NEW YORK, Nov. 29, 2022 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Olaplex Holdings, Inc. (NASDAQ: OLPX), a company...
Silvergate Capital Investor Alert: Kaplan Fox Investigates Silvergate Capital
November 25, 2022 11:58 ET | Kaplan Fox & Kilsheimer LLP
NEW YORK, Nov. 25, 2022 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Silvergate Capital Corp. (“Silvergate” or “Company”)...
Provident Bancorp Investor Alert: Kaplan Fox Investigates Provident Bancorp
November 25, 2022 11:56 ET | Kaplan Fox & Kilsheimer LLP
NEW YORK, Nov. 25, 2022 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Provident Bancorp, Inc. (“Provident” or “Company”)...
Kaplan Fox Continues to Investigate Potential Securities Fraud at Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI) - INVESTOR UPDATE
November 25, 2022 10:59 ET | Kaplan Fox & Kilsheimer LLP
NEW YORK, Nov. 25, 2022 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is continuing to investigate claims on behalf of investors in Spectrum Pharmaceuticals, Inc....
Kaplan Fox Continues Its Investigation Regarding Cryptocurrency Firm FTX
November 23, 2022 17:32 ET | Kaplan Fox & Kilsheimer LLP
NEW YORK, Nov. 23, 2022 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is continuing its investigation of potential claims concerning the crypto exchange platform FTX...
TWST Shareholder Alert: KAPLAN FOX Announces Investigation of Twist Bioscience Corp. for Potential Securities Fraud
November 23, 2022 17:18 ET | Kaplan Fox & Kilsheimer LLP
NEW YORK, Nov. 23, 2022 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Twist Bioscience Corporation (“Twist”) (NASDAQ:...
Bioventus Inc. Shareholder Alert: Kaplan Fox Investigates Potential Securities Fraud (BVS)
November 23, 2022 17:06 ET | Kaplan Fox & Kilsheimer LLP
NEW YORK, Nov. 23, 2022 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Bioventus Inc. (“Bioventus”) (NASDAQ: BVS). If you...
DLocal Limited Shareholder Alert: Kaplan Fox is Investigating Potential Securities Fraud (DLO)
November 23, 2022 16:59 ET | Kaplan Fox & Kilsheimer LLP
NEW YORK, Nov. 23, 2022 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of DLocal Limited (“DLocal”) (NASDAQ: DLO). If you...
Bird Global Investor Alert: Kaplan Fox Investigates Potential Securities Fraud (BRDS)
November 22, 2022 10:19 ET | Kaplan Fox & Kilsheimer LLP
NEW YORK, Nov. 22, 2022 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Bird Global, Inc. (“Bird” or “Company”) (NYSE:...
Kaplan Fox Investigates Potential Securities Fraud at Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI)
November 21, 2022 18:16 ET | Kaplan Fox & Kilsheimer LLP
NEW YORK, Nov. 21, 2022 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors in Spectrum Pharmaceuticals, Inc. (“Spectrum” or the...